Panion’s Q2-19 report, change of CFO, and end of contract for Business Development Director
The board of Panion Animal Health AB (“Panion”) adopted the Q2-19 report on the 29.th of August 2019. At the same meeting, the board took decisions that reflects the strategy for Panion subsequent to CombiGene becoming the major shareholder and the change of members of Panion’s board; · Panion’s Business Development Director, Carlos N. Velez, was thanked for valuable work and input over the years and his contract will be terminated according to the agreement. · The CFO of Panion, Katarina Holm, Er Redovisning i Skåne AB, was thanked for excellent work in the time she served